KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Globus Medical (GMED) Accumulated Expenses (2016 - 2025)

Globus Medical (GMED) has disclosed Accumulated Expenses for 15 consecutive years, with $333.6 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Accumulated Expenses rose 28.01% year-over-year to $333.6 million, compared with a TTM value of $333.6 million through Dec 2025, up 28.01%, and an annual FY2025 reading of $333.6 million, up 28.01% over the prior year.
  • Accumulated Expenses was $333.6 million for Q4 2025 at Globus Medical, up from $157.1 million in the prior quarter.
  • Across five years, Accumulated Expenses topped out at $333.6 million in Q4 2025 and bottomed at $3.9 million in Q3 2022.
  • Average Accumulated Expenses over 5 years is $112.9 million, with a median of $86.3 million recorded in 2021.
  • The sharpest move saw Accumulated Expenses plummeted 95.25% in 2022, then soared 3427.78% in 2023.
  • Year by year, Accumulated Expenses stood at $91.2 million in 2021, then increased by 1.1% to $92.2 million in 2022, then soared by 52.78% to $140.8 million in 2023, then soared by 85.06% to $260.6 million in 2024, then grew by 28.01% to $333.6 million in 2025.
  • Business Quant data shows Accumulated Expenses for GMED at $333.6 million in Q4 2025, $157.1 million in Q3 2025, and $281.7 million in Q2 2025.